| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| CPI-637 |
(R)-4-甲基-6-(1-甲基-3-(1-甲基-1H-吡唑-4-基)-1H-吲唑-5-基)-4,5-二氫-1H-苯并[B][1,4]二氮雜-2(3H)-酮 |
1884712-47-3 |
詳細(xì)
|
| Zofenopril Calcium Salt |
佐芬普利鈣 |
81938-43-4 |
詳細(xì)
|
| Radotinib |
拉多替尼 |
926037-48-1 |
詳細(xì)
|
| BI-847325 |
BI-847325 |
1207293-36-4 |
詳細(xì)
|
| Asciminib |
ABL-001 |
1492952-76-7 |
詳細(xì)
|
| CPI-203 |
CPI-203 |
1446144-04-2 |
詳細(xì)
|
| Mivebresib |
米維布塞 |
1445993-26-9 |
詳細(xì)
|
| 5-(4-(2-(5-Ethylpyridin-2-yl)ethoxy)benzylidene)thiazolidine-2,4-dione |
5-[[4-[2-(5-乙基-2-吡啶基)-乙氧基]苯基]亞甲基]-2,4-噻唑烷二酮 |
144809-28-9 |
詳細(xì)
|
| PFI-3 |
(2E)-1-(2-羥基苯基)-3-[(1R,4R)-5-(2-吡啶基)-2,5-二氮雜雙環(huán)[2.2.1]庚-2-基]-2-丙烯-1-酮 |
1819363-80-8 |
詳細(xì)
|
| Tozasertib |
陶扎色替 |
639089-54-6 |
詳細(xì)
|
| PD-173955 |
6-(2,6-二氯苯基)-8-甲基-2-[[3-(甲硫基)苯基]氨基]吡啶并[2,3-D]嘧啶-7(8H)-酮 |
260415-63-2 |
詳細(xì)
|
| WHI-P180 |
3-[(6,7-二甲氧基-4-喹唑啉基)氨基]苯酚 |
211555-08-7 |
詳細(xì)
|
| SB1317 |
SB1317(混合異構(gòu)) |
1204918-72-8 |
詳細(xì)
|
| Milciclib |
PHA-848125 |
802539-81-7 |
詳細(xì)
|
| Vildagliptin |
維格列汀 |
274901-16-5 |
詳細(xì)
|
| ONO-4059 (hydrochloride) |
ONO-4059 (HYDROCHLORIDE) |
1439901-97-9 |
詳細(xì)
|
| CGI1746 |
N-[3-[4,5-二氫-4-甲基-6-[[4-(4-嗎啉基羰基)苯基]氨基]-5-氧代-2-吡嗪基]-2-甲基苯基]-4-(叔丁基)苯甲酰胺 |
910232-84-7 |
詳細(xì)
|
| PLX-647 |
10MG |
873786-09-5 |
詳細(xì)
|
| Palbociclib Isethionate |
帕布昔利布羥乙基磺酸鹽 |
827022-33-3 |
詳細(xì)
|
| ICEC-0942 |
PPDA-001 |
1805833-75-3 |
詳細(xì)
|
| RGB-286638 Free base |
N-[1,4-二氫-3-[4-[[4-(2-甲氧基乙基)-1-哌嗪基]甲基]苯基]-4-氧代茚并[1,2-C]吡唑-5-基]-N'-4-嗎啉基脲 |
784210-88-4 |
詳細(xì)
|
| AT7519 HCl |
N-(4-哌啶基)-4-(2,6-二氯芐氨基)-1H-吡唑-3-羧胺鹽酸鹽 |
902135-91-5 |
詳細(xì)
|
| Altiratinib |
ALTIRATINIB |
1345847-93-9 |
詳細(xì)
|
| BML-277 |
2-(4-(4-CHLOROPHENOXY)PHENYL)-1H-BENZO[D]IMIDAZOLE-5-CARBOXAMIDE |
516480-79-8 |
詳細(xì)
|
| OSI-930 |
3-[(4-喹啉甲基)氨基]-N-[4-(三氟甲氧基)苯基]-2-噻吩甲酰胺 |
728033-96-3 |
詳細(xì)
|
| MSC2530818 |
MSC2530818 |
1883423-59-3 |
詳細(xì)
|
| Motesanib Diphosphate |
二磷酸莫替沙尼 |
857876-30-3 |
詳細(xì)
|
| Dovitinib |
4-氨基-5-氟-3-[5-(4-甲基哌嗪-1-基)-1H-苯并咪唑-2-基]喹啉-2(1H)-酮 |
405169-16-6 |
詳細(xì)
|
| Motesanib |
莫特塞尼 |
453562-69-1 |
詳細(xì)
|
| BS-181 HCl |
BS181 |
1397219-81-6 |
詳細(xì)
|
| Golvatinib |
N-[2-氟-4-[[2-[[[4-(4-甲基哌嗪-1-基)哌啶-1-基]羰基]氨基]吡啶-4-基]氧基]苯基]-N'-(4-氟苯基)環(huán)丙烷-1,1-二甲酰胺 |
928037-13-2 |
詳細(xì)
|
| (S)-Viloxazine Hydrochloride |
(S)-維洛沙嗪鹽酸鹽 |
56287-61-7 |
詳細(xì)
|
| Simvastatin 4'-Methyl Ether |
辛伐他汀4'-甲基醚 |
864357-88-0 |
詳細(xì)
|
| Simvastatin EP Impurity C |
辛伐他汀雜質(zhì)C |
210980-68-0 |
詳細(xì)
|
| 1β-doxercalciferol |
1BETA-羥基維他命D2 |
127516-23-8 |
詳細(xì)
|
| 1α-Hydroxy VD4 |
1ALPHA-羥基維生素 D4 |
143032-85-3 |
詳細(xì)
|
| Simvastatin EP Impurity I |
辛伐他汀雜質(zhì)I |
79902-42-4 |
詳細(xì)
|
| A-674563 |
A-674563 |
552325-73-2 |
詳細(xì)
|
| 1β-eldecalcitol |
2Α-(3-羥丙基)氧基-1Α,25-二羥基維生素D3 |
158689-03-3 |
詳細(xì)
|
| Simvastatin EP Impurity F |
辛伐他汀雜質(zhì)F |
79952-44-6 |
詳細(xì)
|
| CH5424802 Hydrochloride |
艾樂替尼鹽酸鹽 |
1256589-74-8 |
詳細(xì)
|
| Alfacalcidol Impurity A |
阿法骨化醇EP雜質(zhì)A |
65445-14-9 |
詳細(xì)
|
| 25-Hydroxy Vitamin D3 3,3'-Aminopropyl Ether |
25 - 羥基維生素D33,3' - 氨基丙基醚 |
163018-26-6 |
詳細(xì)
|
| Calcium N5-methyltetrahydrofolate |
5-甲基四氫葉酸鈣 |
26560-38-3 |
詳細(xì)
|
| BAY-1895344 |
BAY-1895344 |
1876467-74-1 |
詳細(xì)
|
| 1,3-bi-TBS-trans-Alfacalcidol |
阿爾法骨化醇中間體 |
112670-85-6 |
詳細(xì)
|
| Eldecalcitol Intermediate CD |
艾地骨化醇中間體CD環(huán) |
144848-24-8 |
詳細(xì)
|
| 25-Hydroxyprovitamin D3 |
25-羥基-7-脫氫膽固醇 |
22145-68-2 |
詳細(xì)
|
| 9β,10α-cholesta-5,7-diene-3β,25-diol |
25-HydroxyluMisterol3 |
61585-29-3 |
詳細(xì)
|
| Eldecalcitol Intermediate A |
艾地骨化醇中間體A環(huán) |
200636-54-0 |
詳細(xì)
|
| Alfacalcidol Impurity B |
(1R,3R,Z)-5 - ((E)-2 - ((1R,7AR)-7A-甲基 - 1 - ((R)- |
63181-13-5 |
詳細(xì)
|
| 11-hydroxy-6-methyl-6,11-dihydrodibenzo[c,f][1,2]thiazepine 5,5-dioxide |
噻奈普汀雜質(zhì) |
26638-56-2 |
詳細(xì)
|
| Sertraline 2,3-Dichloro Ketone Impurity |
舍曲林雜質(zhì) |
152448-80-1 |
詳細(xì)
|
| Defluoro Levofloxacin |
左氧氟沙星去氟代雜質(zhì) |
117620-85-6 |
詳細(xì)
|
| Trospium Chloride Related Compound B |
ALPHA-羥基-ALPHA-苯基苯乙酸 (3-內(nèi)型)-8-氮雜雙環(huán)[3.2.1]辛-3-基酯鹽酸鹽 |
63516-30-3 |
詳細(xì)
|
| (3S,4S)-Tofacitinib |
(3S,4S)-托法替尼 |
1092578-47-6 |
詳細(xì)
|
| (3S,4R)-Tofacitinib |
(3S,4R)-4-甲基-3-(甲基-7H-吡咯并[2,3-D]嘧啶-4-氨基)-BETA-氧代-1-哌啶丙腈 |
1092578-48-7 |
詳細(xì)
|
| (3R,4R)-1-Benzyl-3-(methylamino)-4-methylpiperidine Dihydrochloride |
(3R,4R)-N,4-二甲基-1-(苯基甲基)-3-哌啶胺鹽酸鹽 |
1062580-52-2 |
詳細(xì)
|
| 11-chloro-6-methyl-6,11-dihydrodibenzo[c,f][1,2]thiazepine 5,5-dioxide |
Tianeptine Impurity |
26638-64-2 |
詳細(xì)
|
| Ethyl-Tianeptine-I |
噻奈普汀乙酯碘代物 |
1809277-99-3 |
詳細(xì)
|
| 3-iodo-6-methyldibenzo[c,f][1,2]thiazepin-11(6H)-one 5,5-dioxide |
西替利嗪雜質(zhì) |
1809279-00-2 |
詳細(xì)
|
| sodium 7-((3-iodo-6-methyl-5,5-dioxido-6,11-dihydrodibenzo[c,f][1,2]thiazepin-11-yl)amino)heptanoate |
噻奈普汀乙酯碘代物 |
1809278-35-0 |
詳細(xì)
|
| 6-methyl-3-(trimethylsilyl)dibenzo[c,f][1,2]thiazepin-11(6H)-one 5,5-dioxide |
噻奈普汀雜質(zhì) |
1809278-99-6 |
詳細(xì)
|
| (3S,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride |
(3S,4S)-1-芐基-N,4-二甲基哌啶-3-胺 |
1354486-07-9 |
詳細(xì)
|
| (3S,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine |
托法替尼雜質(zhì) H |
1638499-33-8 |
詳細(xì)
|
| (3R,4S)-1-Benzyl-N,4-dimethylpiperidin-3-amine |
托法替尼雜質(zhì)62 |
1638499-31-6 |
詳細(xì)
|
| 6-methyldibenzo[c,f][1,2]thiazepin-11(6H)-one 5,5-dioxide |
噻奈普汀雜質(zhì) |
26638-46-0 |
詳細(xì)
|
| Verapamil Impurity J HCl |
鹽酸去甲維拉帕米 |
67812-42-4 |
詳細(xì)
|
| OICR 9429 |
OICR-9429 |
1801787-56-3 |
詳細(xì)
|
| (R)-Viloxazine Hydrochloride |
(R)-維洛沙嗪鹽酸鹽 |
56287-63-9 |
詳細(xì)
|
| 15-Keto Travoprost |
15-KETO-曲伏前列素 |
404830-45-1 |
詳細(xì)
|
| Atorvastatin Related Compound E |
阿托伐他汀相關(guān)物質(zhì)E |
1105067-88-6 |
詳細(xì)
|
| Atorvastatin USP Related Compound A |
阿托伐他汀雜質(zhì)A |
433289-83-9 |
詳細(xì)
|
| N-Desmethyl Vandetanib |
N-去甲基凡德他尼 |
338992-12-4 |
詳細(xì)
|
| Ehp-inhibitor-1 |
化合物EHP-INHIBITOR-1 |
861249-59-4 |
詳細(xì)
|
| BMS-794833 |
BMS-794833 |
1174046-72-0 |
詳細(xì)
|
| Crizotinib |
克唑替尼 |
877399-52-5 |
詳細(xì)
|
| Lys05 |
Lys05 |
1391426-24-6 |
詳細(xì)
|
| foretinib |
N-[3-氟-4-[[6-甲氧基-7-[[3-(嗎啉-4-基)丙基]氧]喹啉-4-基]氧]苯基]-N'-(4-氟苯基)環(huán)丙烷-1,1-二甲酰胺 |
849217-64-7 |
詳細(xì)
|
| Savolitinib |
沃利替尼 |
1313725-88-0 |
詳細(xì)
|
| (Z)-JIB-04 |
(Z)-5-CHLORO-2-(2-(PHENYL(PYRIDIN-2-YL)METHYLENE)HYDRAZINYL)PYRIDINE |
199596-24-2 |
詳細(xì)
|
| Ispinesib |
伊斯平斯 |
336113-53-2 |
詳細(xì)
|
| Selumetinib |
司美替尼 |
606143-52-6 |
詳細(xì)
|
| SM-164 |
SM 164 |
957135-43-2 |
詳細(xì)
|
| Nutlin-3b |
Nutlin-3b |
675576-97-3 |
詳細(xì)
|
| Nutlin-3 |
REL-4-[[(4R,5S)-4,5-雙(4-氯苯基)-4,5-二氫-2-[4-甲氧基-2-(1-甲基乙氧基)苯基]-1H-咪唑-1-基]羰基]-2-哌嗪酮 |
548472-68-0 |
詳細(xì)
|
| AT-406 |
AT-406 |
1071992-99-8 |
詳細(xì)
|
| ML324 |
ML324 |
1222800-79-4 |
詳細(xì)
|
| Ehp-inhibitor-2 |
3-(7-amino-3-(pyridin-3-yl)pyrazolo[1,5-a]pyrimidin-6-yl)phenol |
861249-77-6 |
詳細(xì)
|
| KW-2449 |
[4-[2-(1H-吲唑-3-基)乙烯基]苯基]-1-哌嗪基甲酮 |
1000669-72-6 |
詳細(xì)
|
| UNC-2025 |
反式-4-[2-(丁基氨基)-5-[4-[(4-甲基-1-哌嗪基)甲基]苯基]-7H-吡咯并[2,3-D]嘧啶-7-基]-環(huán)己醇 |
1429881-91-3 |
詳細(xì)
|
| SU 5614 |
(3Z)-5-氯-3-[(3,5-二甲基-1H-吡咯-2-基)亞甲基]-1,3-二氫-2H-吲哚-2-酮 |
1055412-47-9 |
詳細(xì)
|
| EPZ-6438 |
EPZ-6438 |
1403254-99-8 |
詳細(xì)
|
| NCGC00244536 |
3-(8-羥基喹啉-6-基)-N-(3-苯基丙基)苯甲酰胺 |
2003260-55-5 |
詳細(xì)
|
| GDC-0084 |
GDC-0084 |
1382979-44-3 |
詳細(xì)
|
| GSK1059615 |
(5Z)-5-[[4-(4-吡啶基)-6-喹啉基]亞甲基]-2,4-噻唑烷二酮 |
958852-01-2 |
詳細(xì)
|
| CC-223 |
CC-223 |
1228013-30-6 |
詳細(xì)
|
| MLN0128 |
3-(2-氨基-5-苯并惡唑基)-1-(1-甲基乙基)-1H-吡唑并[3,4-D]嘧啶-4-胺 |
1224844-38-5 |
詳細(xì)
|
| IMR-1A |
331862-41-0 |
331862-41-0 |
詳細(xì)
|
| PF-04691502 |
2-氨基-8-[反式-4-(2-羥基乙氧基)環(huán)己基]-6-(6-甲氧基-3-吡啶基)-4-甲基吡啶并[2,3-D]嘧啶-7(8H)-酮 |
1013101-36-4 |
詳細(xì)
|